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CHAPTER I  
 
CORRELATING MALDI-IMS AND MRI DIFFUSION MEASUREMENTS  
IN THE C6 RAT GLIOMA MODEL 
 
Introduction 
 This year, it is estimated that more than 1.4 million Americans will be diagnosed 
with cancer and that at least 1,500 will die each day from the disease [6].  Worldwide, 
one in eight deaths are currently attributable to some form of cancer; and the impact of 
cancer on global health is anticipated to rise as the population ages and grows [7].  While 
advancements in diagnosis and treatment methods have yielded an increase in five-year 
cancer survival rates from 50% in 1976 to 66% in 2000 [6], the changes in gross tumor 
morphology which are interrogated by current radiological methods to determine 
treatment efficacy are often unable to report detailed information on tumor status [3, 4, 8] 
indicative of early treatment response [1, 2, 9].  Thus, current methods for assessing 
cancer treatment response may be improved by the use of repeatable and non-invasive 
imaging techniques which provide quantitative measurements of tumor status and 
insights into basic molecular and cellular processes within tissues.  The early application 
of such methods of tissue characterization would permit clinicians to tailor therapy on an 
individual basis based on each patient’s response to a particular agent.   
 Specific macromolecules have been determined to be involved in processes such 
as cell turnover [10 – 12] and angiogenesis, which are crucial for cancer growth [8, 13, 
14].  Consequently, the up-regulation of numerous proteins has been associated with 
tumorigenesis and established as an independent indicator of patient prognosis in several 
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kinds of cancer [1, 2, 9].  The study presented in this thesis is motivated by the theory 
that the ability to non-invasively identify signatures of up-regulated proteins in cancerous 
tissue would facilitate further molecular studies and discovery of unknown biomarkers of 
cancer.  The overarching goal of this work is to examine the spatial correlation between 
noninvasive magnetic resonance imaging (MRI) metrics and their underlying quantifiable 
molecular-level physiological processes which cannot be obtained noninvasively.  Thus, 
an interdisciplinary approach, drawing on aspects of cancer biology, imaging technology, 
and computational, mathematical, and chemical analyses is employed to address the 
following core study components:  
 
Objective:  To enhance the understanding of the molecular-level influences on 
diffusion maps provided by MRI in the C6 rat glioma model of brain cancer.  
 
Hypothesis:  It is hypothesized that tumor protein signatures in C6 rat gliomas 
correlate spatially with tumor diffusion measurements and cellularity. 
 
Specific Aims 
Specific Aim 1:  Development and automation of techniques for co-
registration of in vivo diffusion-weighted MRI and ex vivo matrix-assisted 
laser desorption (MALDI) measurements. 
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Specific Aim 2:  Statistical analysis of co-registered measurements to 
determine the correlation between levels of specific tumor-expressed 
proteins and water diffusion rates reported by MRI.  
 
A discussion of features of the above-mentioned fields which are relevant to this study is 
presented next.  
 
Background 
 
The C6 Glioma Rat Tumor Model 
 The C6 Glioma cell line is often used in rats as a model of brain cancer [15] 
which is morphologically similar to human glioblastoma multiforme (GBM) [8], an 
aggressive cancer of the glial cells with a median patient survival of less than one year 
[16].  In general, rodent models of brain cancer maintain several important aspects of the 
complexity of the disease, including inflammatory response and neovasculature 
development [8].  Moreover, intracranial injections of C6 cells into Wistar rats in 
particular yield solid malignant tumors which develop necrotic cores and display a level 
of polymorphism characteristic of human GBM [8] 
 C6 cells grow preferentially around blood vessels, with invasiveness directed 
along neuronal fibers [8].  Unfavorable cellular microenvironmental factors prevent 
mitosis of isolated mobile C6 cells in Wistar rats [8].  Thus, invasion of surrounding 
brain tissue is accomplished not by cellular proliferation but via an alternate method in 
which individual C6 cells release proteolytic enzymes that generate micropockets which 
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degrade the extracellular matrix [8].  Degeneration and remodeling of the basement 
membrane facilitates angiogenesis, providing increased delivery of oxygen and nutrients 
from the neovasculature to the primary tumor [8].   
 Several proteins have been identified in association with the cell-cell and cell-
matrix interactions crucial to C6 cellular invasion and angiogenesis, including vascular 
endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), matrix 
metalloproteinase II (MMP2), as well as various adhesion molecules, proteases, and 
cytokines [8].  Of note, commonly used chemotherapies which target actively 
proliferating tumor cells are less effective in the prevention of C6 cell invasion than 
therapeutic agents which disrupt cytoskeletal assembly [8].   
 
Diffusion and Cellularity in Healthy and Cancerous Tissues  
 Water molecules in solution undergo random, thermally-induced movement 
referred to as self-diffusion or Brownian motion [17, 18].  Although the net displacement 
of water molecules diffusing through tissue is zero, the path length traversed by 
individual water molecules is time-dependent and can be described by 
                 
2
r DT2= ,    (Equation 1) 
where 2r  is the square of the average path length, D is the rate or coefficient of 
diffusion (3.0 × 10-3 mm2/s for pure water at 37º Celsius [17, 19]), and T is the time of 
observation of the water molecule's motion [18].  For water in cellular tissues, D is found 
to be much lower than that of water in free solution [17]. 
 Physiologically, the diffusion of water molecules in brain tissue is restrained by 
the presence and degree of permeability of structures within the tissue that inhibit the 
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mobility of water molecules.  Examples of such barriers include cell membranes, white 
matter tracts, proteins, and collagen fibers [20].  Since tumor growth is characterized by 
unchecked cellular proliferation, the development of tortuous vasculature, and 
upregulation of proteins associated with the generation of these features, the self-
diffusion of water molecules in cancerous tissues often varies from that of healthy, well-
organized tissues of the same type.  Thus, by examining the rate of water diffusion in a 
particular tissue, certain features characteristic of the nature of barriers encountered by 
the diffusing water molecules may be studied.  Specifically, cellularity, which 
characterizes the number and state of cells in a given tissue volume, has been found to 
correlate inversely with the diffusion rate of water in breast, brain, and renal cancers [20 
– 23].   
 Quantitatively, cellularity may be defined as the ratio of the total area of tumor 
cell nuclei relative to the total area of the tissue of interest [24].  Since cell membranes 
can serve as effective barriers to diffusing water molecules, increases in cell density 
result in restricted water diffusion, while decreases in the number of cells in a given 
tissue region reduce the number of barriers, therefore resulting in less restricted diffusion 
of water.  Thus, determination of the diffusion rate of water molecules for a given type of 
tissue provides a means by which cell density may be assessed [17]. 
 
Measuring Diffusion via MRI 
 The rate of self-diffusion of water in tissue is described by an apparent diffusion 
coefficient (ADC) measured in units of area/time.  The ADC can be measured 
noninvasively via modification of a traditional magnetic resonance imaging (MRI) 
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excitation technique, the spin-echo pulse sequence [25, 26].  Spin-echo pulse sequences, 
depicted in Figure 1 (Panel A), begin with the application of a 90º radiofrequency (RF) 
pulse to establish spin phase coherence in the transverse plane (relative to the direction of 
the applied static magnetic field) [27].  After some time, T (on the order of tens to 
hundreds of ms), dephasing occurs due to the effects of spin-spin interactions and 
magnetic field inhomogeneities [27].  A 180º RF pulse is then applied to nutate the spin 
precession to its mirror image [27].  After passage of an additional time T , phase 
coherence is re-established, producing the maximum MR signal acquired at time TE  
[27].   
 
 
Figure 1: Spin-echo and diffusion-weighted MRI pulse sequences.  Spin-echo pulse 
sequences (Panel A, top) utilize 90º and 180º RF pulses to achieve maximum spin phase 
coherence and consequent maximum MR signal intensity.  Diffusion-weighting is 
accomplished via application of spatially-varying diffusion gradients before and after the 
180º RF pulse (Panel B, bottom).  The first gradient causes a spatially-dependent change 
in phase, while the second gradient reverses the phase change to an extent due to 
molecular mobility.  Phase dispersion in locations of mobile molecules yields attenuation 
of MR signal intensity, thus indicating regional relative diffusion rates. 
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 Diffusion weighting of the spin-echo pulse sequence involves application of two 
equal diffusion gradient pulses before and after the 180º pulse, as indicated in Figure 1 
(Panel B), [25, 26].  The incorporation of diffusion gradients results in diffusion-
dependent attenuation of the MR signal intensity via the mechanisms described below 
and illustrated in Figure 2. 
 
 
Figure 2: Effects of diffusion gradient application on phase coherence for a pair of mobile 
molecules and a pair of non-mobile water molecules in one dimension.  After the 90º RF 
pulse, water molecules (blackened circles) at all positions, x , possess identical phase, 
φ (indicated by the direction of the black arrows), as shown in the top panel.  At some 
time, t , before application of the spin-echo 180º RF pulse (not shown), a spatially-
varying diffusion gradient is applied, generating a spatially-dependent change in phase of 
the water molecules (middle panel) at each position x .  At a time t  after application of 
the spin-echo 180º RF pulse, a second diffusion gradient is applied (bottom panel) which 
negates the phase-changing effects of the first diffusion gradient on stationary water 
molecules (bottom right) yet amplifies phase decoherence of diffusing water molecules 
(bottom left).  Since maximum MR signal intensity is obtained in regions of full phase 
coherence, tissue regions characterized by high water mobility demonstrate attenuation in 
localized MR signal intensity; whereas tissue regions of low diffusion generate signal 
intensities similar to those which would have been generated in the absence of diffusion 
gradient application.   
 
 Consider a set of hydrogen atoms located within water molecules in biological 
tissue.  The protons possess spins which are in phase immediately after the application of 
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the 90º rephasing pulse (Figure 2, top panel) [18]. After some time, typically tens of ms 
[17], a spatially varying diffusion gradient is applied (Figure 2, middle panel) such that a 
spin at position xi acquires an additional phase component, iφ , given by 
            δγφ xii Gx−= ,    (Equation 2) 
whereγ is the gyromagnetic ratio, xG is the amplitude of the diffusion gradient, and δ is 
the duration of the diffusion gradient pulse.  A second diffusion gradient, applied after the 
180º pulse (Figure 2, bottom panel), causes the spins at position xj to acquire a second 
additional phase component, jφ , where  
            δγφ xjj Gx= .    (Equation 3) 
 Thus, for non-mobile water molecules with ji xx =  and iφ =- jφ , the absence of a 
resulting net phase change yields a signal intensity similar to that which would have been 
obtained without diffusion weighting [18].  However, for diffusing water molecules, 
xi ≠ xj and ≠iφ jφ , causing these molecules to experience a net phase difference, φ∆ , 
given by 
         )( ij xxG −=∆ δγφ .    (Equation 4) 
 Within any volume of tissue, there will be signal contributions from multiple 
values of φ∆ , which interfere destructively and cause signal "dephasing."  This 
dephasing results in localized loss of signal intensity in displaced water molecules in the 
tissue being imaged [18].   
 The measured MR signal intensity, S , obtained from the spin-echo and diffusion-
weighted pulse sequences are  
     
21 //
0 )1( TTETTR eeSS −−−=     (Equation 5) 
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and 
  
ADCbTTETTR eeeSS •−−−−= 21 //0 )1(     (Equation 6) 
respectively, where 0S  is the signal intensity prior to application of field gradients; TR 
and TE are the pulse repetition and echo times, respectively; T1 and T2 are the 
longitudinal and transverse relaxation times, respectively, of the bulk magnetization 
vector.  The b-value is a variable which reflects the strength and duration of the diffusion-
sensitizing gradient.  The gradient amplitude, xG , duration, δ , and temporal spacing, ∆  
(not to be confused with the change in phase, ∆ , of Equation 4), between the applications 
of the first and second diffusion gradients are incorporated into the b-value as given by 
[25] 
           )
3
()( 22 δδγ −∆= Gb .    (Equation 7) 
 The ADC can be calculated via linear regression analysis, with the applied b-
values as the independent variable and the logarithm of the ratio of signal intensities of 
MR datasets collected at multiple b-values, )(bS , to the non-diffusion weighted signal 
intensities, S , as the dependent variable  [28].  The ADC at each voxel is the slope of the 
linear fit, which may be rearranged to be defined by   
          
S
bS
b
ADC )(ln1−= .    (Equation 8) 
 Since the magnitude of diffusion weighting in MRI is dependent upon the applied 
b-value, several considerations are important in selecting which b-values to use in 
determination of ADCs.  First, signal intensity measurements incorporate diffusion 
gradient spacing and duration ( ∆  and δ , respectively, in Equation 7) which must provide 
adequate time for diffusing water molecules to encounter barriers [29].   That is, for short 
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measurement times, the distances traversed by mobile water molecules may be 
insufficient for them to arrive at diffusion boundaries, thus yielding measurements which 
result in high ADCs that do not reflect cellularity [29].  In addition, the use of low b-
values (less than 300 s/mm2) may result in overestimation of ADCs due to low b-value 
sensitivity to the motion of rapidly moving water molecules, such as those in blood 
vessels and microvasculature [30, 31]. 
 Larger b-values (greater than 1200 s/mm2) may also yield overestimated ADC 
values and consequent signal loss, due to their necessity for larger repetition times which 
increase the incidence of motion artifacts and decrease the signal-to-noise ratio (SNR) 
[30, 31].  Nevertheless, larger b-values provide greater sensitivity to slower-moving 
molecules in both intra- and extra-cellular spaces [31], and may be of greater use in 
determination of therapeutic response in cellular tissues, owing to the relative 
insensitivity of larger b-values to diffusion in highly edematous tissues [17].  Of note, the 
use of relatively short echo times improves SNR, yet limits the range of b-values which 
may be applied during image acquisition (see Figure 1) [31].  Overall, many studies of 
microstructural tissue characteristics by diffusion-weighted imaging have employed b-
values ranging several orders of magnitude, from 0 s/mm2 (T2 weighted) up to several 
thousands of s/mm2 [17, 31-36]. 
 While many considerations affect diffusion of water in biological tissues, the 
ADCs of brain tissue exhibit particular complexity, due to the heterogeneous structure of 
both healthy and pathologic brain tissue.  For example, the diffusion rate of water is 
much lower in regions characterized by densely packed fiber tracks, such as white matter 
and the corpus callosum, than in water-rich regions scarce in barriers to diffusion, such as 
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the ventricles [26, 37].  Further confounding factors are present when tumor growth 
affects the ADC of white matter tracts by disrupting their structural integrity [37].  
Moreover, the ADCs of brain tumors may vary across the extent of the tumors, with 
markedly different values found in necrotic cores (i.e., central regions of non-viable cells) 
than in actively proliferating outer rims and regions of infiltration [17, 37].  In addition, 
ADCs in regions of peritumoral edema may be higher than those of tumor boundaries, 
especially in cases of tumor metastases [17, 37].   
 Examination of the wide variations in ADCs of different regions of the brain 
demonstrates the necessity of describing diffusion rates for specific tissue subtypes and 
underscores the need for judicious selection of regions of interest in evaluation of brain 
ADCs.  To further illustrate, diffusion rates of specific selected healthy and pathologic 
brain tissues are listed in Table 1. 
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Table 1: ADCs of selected healthy and cancerous brain tissues.  The diffusion of water in 
healthy white matter is hindered by the presence of fiber tracts, yielding low ADCs in this 
tissue.  Relatively low diffusion rates are also seen in malignant and cellularly dense 
tumors as compared to necrotic tissue, which is characterized by low cellularity.  The 
ADCs of water-rich cerebrospinal fluid and cysts are comparable to that of pure water at 
body temperature (included for reference). 
 
Tissue Description ADC  
(× 10-3 mm2/s) 
Reference 
Frontal White Matter 0.79 38, 39 
Parietal White Matter 0.78 38 
Deep Gray Matter 0.75 38 
Parietal Gray Matter 0.85 39 
Thalamus 0.85 39 
Cerebellar Hemisphere 0.73 39 
Cerebrospinal Fluid 2.9 39 
Edematous Brain 1.3 - 1.4 17 
Cyst 2.5 - 3.5 17, 19 
Cellularly Dense Brain Tumor 0.60 17 
Solid High-Grade Glioma 0.80 -1.3 17 
Necrotic Glioma Core 1.8 - 2.4 17 
Pure Water (Body Temperature) 3.0 17, 19 
 
Matrix-assisted Laser Desorption Time-of-Flight Mass Spectrometry 
 The up-regulation of numerous proteins and peptides has been associated with 
tumorigenesis, especially those molecules involved in cellular proliferation, extracellular 
matrix degradation, and angiogenesis [40-43].  Matrix-assisted laser desorption ionization 
(MALDI) is a technique by which protein signatures may be identified and localized 
within intact ex vivo biological tissue specimens based on the molecular weight of the 
protein [44].  However, to uniquely specify individual proteins, additional analytical 
methods such as time-of-flight (TOF) mass spectrometry (MS) are often employed to 
yield information which supplements the molecular weights reported by MALDI [45-47].  
MALDI methods are sensitive to proteins with masses ranging from 2 – 70 kDa [44, 45] 
 13 
(note that peptides and proteins in murine tissues most often fall within the range of 2 – 
30 kDa [44]).  The mass measurement accuracy of combined MALDI-TOF-MS ranges 
from 100 – 200 ppm and the molecular sensitivity is in the attomole to femtomole range 
[2].  
 MALDI-TOF-MS instrumentation functions to provide proteomic information 
principally by means of separating ions based on their charges and molecular masses 
[47].  Components of a MALDI-TOF mass spectrometer are depicted schematically in 
Figure 3.  The specimen to be analyzed (preparation techniques described below) is 
placed in a vacuum chamber and kept at a positive potential, typically 20 kV [47].  Select 
sample regions are then struck by photons, most commonly produced by nitrogen lasers 
yielding 337.1 nm pulses which are maintained for a duration of three ns [47].  The laser 
pulses cause the proteins within the sample to ionize, desorb, and enter the gas phase 
[48]. 
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Figure 3: Schematic diagram of a linear MALDI-TOF mass spectrometer.  The sample is 
held at an electric potential.  Charged molecules are desorbed from the sample by 
impinging photons from a pulsed laser.  Subsequent to being held briefly in a free-field 
region, the ions are accelerated down a flight tube towards a detector which records the 
number and arrival time of the ions.  The entire system is held in vacuum.  
 
 In modern mass spectrometers, a delayed extraction (DE) grid is employed to 
improve mass resolution [47].  The DE grid is held at a potential equivalent to that 
applied to the sample plate, thus restraining the ion plume in a free-field region for time 
periods on the order of hundreds of ns [47, 48].  During the delay period, most neutral, 
light molecules diffuse away from the relatively heavier molecules of interest, which in 
turn travel a mass-dependent distance between the sample and the grid [47].  Upon 
completion of the delay period, the DE grid voltage is abruptly reduced, yielding graded, 
pulsed acceleration of the (fixed kinetic energy) ions through a grounded grid, followed 
by their drift through a flight tube towards the detector [47, 48].  The time of flight 
initiation is marked by the time of laser pulse collision with the sample and duration of 
DE, whereas the flight end time is recorded by the detector [46, 47]. 
Linear 
Detector 
Pulsed 
Laser 
DE Grid 
Pulsed Ion 
Beam  
Sample Plate 
(20kV) 
0 V Grid Vacuum 
Ions (Matrix 
+ Analyte) 
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 The mass to charge ratio of an ion may be readily calculated from the observed 
flight time.  The potential energy, pE , at which the sample plate is held is given by 
                zUE p = ,  (Equation 9) 
where z is the charge of the ion and U is the voltage across the plate [49].  As the ions 
are desorbed, the potential energy is converted to a fixed kinetic energy, kE , of 
             
2
2
1
mvEk = ,  (Equation 10) 
where m is the ion mass and v is the ion velocity [49].  Since the velocity of the ions in 
the vacuum drift tube is constant, v  may be expressed as
t
L
, where L  is the length of the 
flight path and t  is the total time of flight.  The equivalence of potential and kinetic 
energies thus yields 
            
2
2
1






=
t
L
mzU .  (Equation 11) 
Rearrangement of Equation 12 clarifies that the ion mass to charge ratio and flight time 
are related via known constants, U  and L , by 
               2
22
L
Ut
z
m
= .  (Equation 12) 
Using this relationship, the record of the number of ions striking the detector is converted 
to spectra corresponding to mass to charge ratios and their relative intensities (peak 
amplitudes) [48]. 
 To assure detailed and accurate measurements, strict adherence to careful 
specimen preparation procedures is necessary when undertaking MALDI experiments.  
Since albumin, immunoglobulins, and other high-abundance proteins may comprise more 
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than 90% of plasma and serum protein mass, exsanguination of animal subjects is often 
performed to prevent blood protein signatures from dominating MALDI signals from 
low-abundance proteins [5, 50, 51].  The exsanguination process involves removal of 
blood from the animal by saline perfusion via cardiac puncture, after which the tissue of 
interest is typically rapidly frozen to inhibit protein degradation.  Tissue specimens are 
then sliced into sections using a surgical blade, microtome, or cryostat, to achieve slice 
thicknesses on the order of tens of microns [5, 52]. 
 Tissue specimens are then further prepared for MALDI analysis by the 
application of a matrix compound such as that shown in Figure 4 [45, 46]. 
 
 
Figure 4: Chemical structure of sinapinic acid, a commonly used MALDI matrix for 
analysis of proteins [47].  The acidic matrix, MH+, is applied to a sample, S, with which it 
cocrystallizes.  Within the mass spectrometer,  photons emitted by the pulsed laser strike 
the specimen, ionizing the sample as protons, H+, are contributed by the matrix to the 
sample according to the reaction: MH+ + S  M + SH+.  The ionized sample molecules 
are then analyzed via TOF techniques in order to determine their mass to charge ratios. 
 
 MALDI matrices serve several functions, including cocrystallization of extracted 
analyte (i.e., macromolecules within the tissue specimen) over the surface of the 
specimen, protection of analyte structure by absorption of the energy of applied laser 
pulses, and ionization of the analyte molecules via contribution of one or more protons or 
electrons from the matrix to the analyte, depending on the relative pH between the matrix 
and the analyte [45-47]. 
CH3O 
HO 
CH3O 
CH    H    COOH 
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Data Analysis 
 MALDI data collected during the course of this project will be examined using 
principal component analysis (PCA), a data-driven multivariate statistical technique that 
requires minimal a priori assumptions regarding latent variables [53].  In addition to its 
application in mass spectrometry [53], PCA has found use in a variety of fields, including 
image processing and compression, immunology, molecular dynamics, information 
retrieval, and others [54]. 
 Several features of PCA contribute to its widespread success as an analysis 
method.  For example, PCA techniques are able to detect weak signals in data, which is 
useful in denoising [53] and offers the potential to overcome limitations inherent to 
cluster analysis [54].  Furthermore, dimensionality reduction with little loss of 
information may be achieved using PCA by focusing analysis on only the most dominant 
data components (i.e., those which exhibit the highest degrees of variance) [53, 54].  
These characteristics of PCA render it a powerful method for unbiased exploration of 
those protein signatures and diffusion measurements which share a common spatial 
distribution.   
 To begin PCA of MALDI data, a matrix M  of dimension pn × is constructed in 
which n is the number of voxels sampled by MALDI and p  is the number of discrete 
MALDI peaks at each voxel location  The mean energy, ms , of M  is calculated as  
             
n
ms
ms
ni
i
i∑
=
=
=
1
   (Equation13) 
where ims  is the MALDI mass spectrum measurements of the i
th
 imaging voxel.  To 
decrease the effects of noise and reduce the number of MALDI peaks to a 
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computationally efficient number (e.g., from approximately tens of thousands to several 
hundred), an energy threshold may be set, below which all values are omitted from 
analysis.    
 A MALDI covariance matrix is then constructed and decomposed via singular 
value decomposition.  Multiplication of each eigenvector by the original MALDI data 
generates a linear combination of eigenimages in which the entire MALDI dataset, M , is 
represented by 
            ∑
=
=
=
imagesj
j
jj EM
#
1
α ,   (Equation14) 
where jα is the jth eigenvalue (i.e., weighting factor), and jE is the jth eigenimage.  Each 
eigenimage then represents the relative concentration of MALDI data in space (i.e., how 
well the eigenvalue corresponds to a point in space).  Thus, the application of PCA will 
permit examination of the contributions of independent eigenimages to correlations 
between ADC and proteomic metrics.  
To examine the relationship between ADC and protein mass to charge ratios, the 
Pearson correlation coefficient, r, between each eigenimage and the ADC values in 
selected regions of interest (ROIs) will be calculated as  
∑∑
∑
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=
=
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, (Equation 15) 
where iX  and iY  are the i
th
 ADC and eigenimage intensity measurements, respectively, 
and X and Y are the mean values of all ADC and eigenimage intensity measurements, 
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respectively [55, 56].  The significance of each correlation will be expressed using 
traditional p-value representation. 
 
Methods 
 
Animal Model 
 Animal procedures were approved by Vanderbilt University's Institutional Care 
and Use Committee.  Two Wistar rats with an average mass of 250 g were anesthetized 
with a 2%/98% isofluorane/oxygen mixture.  The rats were then injected with 1 ×  105 C6 
glioblastoma cells using a 10-mL gastight syringe approximately one mm anterior and 
two mm lateral to the bregma on the right side of the head, at a depth of three mm relative 
to the dural surface.  Intracranial tumors emerged in one of the rats while one rat was 
found to develop only inflammation due to the needle insult.  The latter rat was then 
selected to be used as a control.  15-16 days post-injection, the rats were anesthetized 
with a 2%/98% isofluorane/oxygen mixture and diffusion-weighted MR imaging was 
performed as described below. 
 
MRI Protocol 
 MR data were acquired on a 9.4 T Varian DirectDrive scanner equipped with a 38 
mm Litz coil and an in-house constructed rat restraint device to minimize motion.  TR 
and TE values were 2000 and 25.56 ms, respectively.  Diffusion gradient duration,δ , of 
6 ms and spacing, ∆ , of 15 ms, were used with amplitudes of 0, 6.31, and 9.98 mT/m, to 
yield b-values of 0, 400, and 800 s/mm2.   Data were collected in 128 ×  96 matrices 
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spanning a 38.4 ×  28.8 mm FOV achieving an in-plane resolution of 300 ×  225 µm.  The 
slice thickness was 0.5 mm with no gap between slices.  Six image acquisitions were 
averaged for each rat. 
 The MR data was then imported into Matlab for analysis.  Diffusion maps were 
generated for each slice of the two rat datasets using an in-house developed program 
which implemented linear regression analysis described by Equation 8.  A selected 
diffusion map and the MR data from which it was generated are shown in Figure 5. 
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Figure 5: Diffusion-weighted MR images and ADC map for central slice of the tumor rat 
dataset.  Clockwise from top left: MR images acquired with b-values of 0, 400, and 800 
s/mm2, respectively (units: arbitrary MR signal intensity), and the corresponding ADC 
map (units:  mm2/s).  The location of the glioma is indicated by the red arrow (top left) 
and is visible in all three MR images as a relatively large, asymmetric region of 
heterogeneous signal intensity.  The MR signal intensities of the three images are 
depicted on the same scale.  Note the overall decrease in signal intensity as b-values are 
increased.  The glioma is also observable as a region of variable diffusion rates in the 
ADC map.  The largest ADC values appear in regions that have limited barriers to 
diffusion (see, e.g., the eyes and right ventricle).  
 
MALDI Imaging Procedures 
 Immediately after in vivo MR data acquisition, a deep level of anesthesia was 
induced in each rat.  The rats were then sacrificed via exsanguination and decapitated.  
The heads were flash-frozen in a hexane and dry ice solution and subsequently placed in 
a water bath which was frozen at -20º C until the time of the sectioning procedure.  The 
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frozen rat heads were sectioned (Leica CM3600 Cryomacrotome) into 15 µm slices, with 
a mounted high resolution digital Canon camera system used to photograph every other 
slice for registration purposes (described below).   
 Specimen slices were placed on indium-tin-oxide coated glass plates and spotted 
with a MALDI matrix solution of 20 mg/mL sinapinic acid prepared in 50% acetonitrile 
and 0.1% trifluoroacetic acid.  Ion images were acquired with 200 µm lateral resolution 
using a linear MALDI time-of-flight mass spectrometer (Autoflex III, Bruker Daltonics) 
equipped with a Smartbeam™ solid state Nd:YAG (i.e., neodymium-doped yttrium 
aluminium garnet) laser with an emission wavelength of 355 nm operating at 200 Hz.  
Each pixel was represented by the accumulation of 200 laser shots arranged in four 
different positions with a shot diameter of 150 microns as depicted in Figure 6.  Mass 
spectra were collected for molecules with mass to charge ratios within the range of 2 to 
40 kDa/charge. 
 
Figure 6: Arrangement of 200 MALDI laser shots in a single pixel.  Four different 
positions in each pixel received 50 laser shots.  The diameter of each laser shot was 150 
µm and the center-to-center distance between the shot positions was 200 µm.  
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Coregistration of MR and MALDI Datasets 
 Using Matlab applications developed by the Center for Image Analysis of the 
Vanderbilt University Institute of Imaging Science, coregistered MALDI/ADC datasets 
were created for three slices each of control and tumor rat data, for a total of six datasets.  
The registration process relied on a three-dimensional (3D) digital construct, termed the 
"blockface", which served as an intermediate reference structure to which the MR and 
MALDI data were aligned to produce a registered multi-modal data set [5].  The 
blockface was comprised of the set of digital photographs of the rat heads obtained 
during sectioning of the specimens.  The blockface volume was generated by an iterative 
alignment process in which each photograph was registered to the previous one using an 
intensity based algorithm based on normalized mutual information (NMI).1   
 The control rat blockface volume contained 450 photographs acquired at intervals 
of 30 µm to yield a total depth through the rat head of 13.53 mm (see Figure 7).  The total 
depth represented in the blockface volume for the tumor rat was 22.89 mm (763 
photographs).  The estimated random error in depth assessment was 100 µm.  
 
 
1
 NMI optimizes the similarity between two images by translation and in-plane rotation of the registration image to the target image 
to achieve a minimum in the NMI metric, joint entropy [57].  
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Figure 7: Subset of control rat blockface data.  Three out of 450 photographs are shown 
with the slice depth relative to bregma indicated in the lower right corners of the images.   
 
 The two-dimensional locations within the tissue from which spectra were 
acquired were reported by the spectrometer during specimen analysis, thus intrinsically 
associating the MALDI with the corresponding tissue locations in the 3D blockface.  
Finally, the blockface data were registered to the MRI dataset using a six degree-of-
freedom rigid body (with the skull as a stereotaxic frame) NMI-based technique.  Due to 
lower resolution of MR data relative to MALDI data, ADC values which were missing 
for points in space corresponding to the MALDI measurements were interpolated using 
nearest neighbor methods.  
 
 
 
4.35 mm   
4.65 mm  
4.95 mm  
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Correlation Analysis 
 Application of PCA with a 1% energy threshold reduced the number of MALDI 
peaks from approximately 20,000 to 500.  A 500 ×  500 covariance matrix of the MALDI 
data was generated and decomposed via SVD.  Each eigenvector was multiplied by the 
original MALDI data to yield a linear combination of 20 eigenimages.   
In each of the six datasets, regions of interest (ROIs) within selected anatomical 
structures were manually delineated using in-house developed Matlab code.  Anatomical 
features in the control rat were somewhat difficult to observe in the diffusion-weighted 
MR values translated into MALDI space.  Thus, only two ROIs (those in the rat eyes) 
were delineated in the ADC data in MALDI space.  The selection of an additional 25 
ROIs was based on visual inspection of T1-weighted MR data from the same rats 
(obtained during the same MR sessions for use in a separate study), which were also 
coregistered with the MALDI data.  The ROI coordinates for the eyes in the ADC data 
and the 25 other ROIs from the T1-weighted data were concatenated to yield three-
dimensional data coordinates specifying the locations of a total of 27 ROIs in the first 
slice of control rat data.  ROIs in T1-weighted data for the first control slice are shown in 
Figure 8. 
In the control rat, a total of 75 ROIs which corresponded to similar inter-slice 
structures were selected for correlation analysis.  In each of the first and second slices, 27 
ROIs were defined within apparently contiguous structures, while only 21 of the regions 
were present in the third (deepest, relative to bregma) slice.  For example, ROIs were   
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Figure 8: ROIs in T1 data translated into MALDI space for control rat slice one.  ROIs in 
ADC values in MALDI space were identified in each rat eye (ROIs 1 and 5).The T1 data 
were used for manual identification of most ROIs (25 of 27), due to the ease of 
observation of anatomical features in T1-weighted MR data.  The two sets of ROI 
coordinates were concatenated after selection within the two MR datasets. 
 
delineated within the dentate gyrus, lateral ventricles, and portions of the hippocampus in 
slices one and two.  However, these structures were not visible at the depth of the third 
slice.  Thus, each of these structures was omitted from analysis in the third slice, causing 
six contralateral ROIs to be absent from the third slice which were present in the first 
two.  Figures depicting the ROIs for each of the control slices in the ADC data are 
included as Figures 16 – 18 in the Additional Figures section.  The anatomical structures 
corresponding to each ROI in the control rat data are listed in Table 2 [58]. 
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Table 2: Anatomical structures selected as ROIs within the control rat data. 
Anatomical Structure  ROI Number(s) 
Eyes 1, 5 
cingulate cortex 2, 4 
rhinal incisura 3 
cortex, rostrolateral 6, 27 
caudate putamen 7, 26 
lateral ventricle 8, 24 
cortex, mediolateral 9, 25 
Hippocampus 10, 23 
dentate gyrus 11, 22 
superior colliculus 12, 20 
cortex, posteriolateral 13, 21 
inferior colliculus 14, 20 
Cerebellum, lateral 15, 18 
Cerebellum, medioanterior 16 
Cerebellum, medioposterior 17 
 
 Anatomical features were obscured to a greater extent in the tumor rat than in the 
control rat due to variations in the orientation of the rat head during MR imaging and 
MALDI sectioning.  Furthermore, diagonal "streaks" were observed in each slice of the 
tumor ADC data translated into MALDI space.  These visual phenomena were 
presumably caused by distribution of the dynamic tumor MR data across the MALDI 
imaging plane.  Nevertheless, the tumor rat data permitted selection of 29 ROIs 
corresponding to 13 inter-slice regions of similar feature, if not actual anatomical 
structure.  The ROIs in ADC data for the first tumor slice are shown in Figure 9, while 
those for the second and third are included as Figures 19 and 20 in the Additional Figures 
section.  The anatomical regions corresponding to each ROI in the tumor rat data are 
listed in Table 3 [58]. 
 28 
 
Figure 9: ROIs in ADC data translated into MALDI space for tumor rat slice one.  Data 
quality reflects misalignment of the rat head during MR imaging and MALDI sectioning, 
as well as the distribution of dynamic MR data across the resolution of the MR scanner. 
 
Table 3: Anatomical regions selected as ROIs within the tumor rat data. 
Anatomical Region  ROI Number(s) 
left eye 1 
cortex, rostrolateral 2 
cortex, mediolateral   3, 8 
right lateral ventricle 4 
cortex, posteriolateral 5 
hippocampus, right 6 
dentate gyrus, left 7 
tumor outer rim 9 
tumor core 10 
tumor, left diagonal ROI 11 
tumor, medial diagonal ROI 12 
tumor, right diagonal ROI 13 
 
 
 For each rat, the correlations between ADCs and eigenimage intensities in each 
ROI were calculated on a voxel-by-voxel basis using the Pearson correlation coefficient, 
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r, and p-value significance ratings.  Also for each rat, two-sample t-tests were conducted 
to determine the statistical equivalence, or lack thereof, between the ADC populations of 
both intra- and inter-slice ROIs.  ADC similarities were not compared between the two 
rats. 
 Separately in each of the rats, ROIs within contiguous inter-slice anatomical 
regions which featured similar ADCs while concurrently exhibiting dissimilar intra-slice 
ADCs were selected for further analysis.  For example, relatively high ADCs were 
present in the rhinal incisura of all slices, as compared to lower ADCs observed during 
intra-slice comparisons between the rhinal incisura and the cerebellum.  Specific 
eigenimages which correlated significantly with these ROIs' ADCs were compared in 
order to examine the theory that, within a given tissue type, equivalent ADCs may be 
correlated with identical protein signatures.  For the results which were consistent with 
this theory, the eigenspectra used to generate the eigenimages that correlated with the 
selected ROIs' ADCs were inspected for the presence of specific mass to charge ratios 
which exhibited high-amplitude spectral intensities in each slice's eigenspectrum.  A 
literature search was then conducted to identify possible proteins represented by these 
values of mass to charge ratios. 
 
Results and Discussion 
 
Overall Correlations between ADC and Eigenimages 
 The linear Pearson correlation coefficient, r, and associated p-values were 
calculated between the ADC values of each voxel within each ROI and each of 20 
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eigenimages for a total of 75 ROIs representing 27 anatomical structures in the control rat 
and 39 ROIs corresponding to 13 different anatomical regions in the tumor rat.  The 
correlations were classified as statistically significant when their associated p-values were 
≤  0.05.  As summarized in Figure 11, significant correlations were identified in 44.0% 
(41.2% of control; 49.4% of tumor) of all calculations of correlations between ADC and 
eigenimage intensity in all ROIs.  For the correlations between ADC and eigenimages 
which were deemed significant, the mean r-value for the control rat was 0.348 ±  0.137.  
For the significant correlations of the tumor rat, the mean r-value was 0.331 ±  0.122.  
Since the eigenimages represent the relative concentration of MALDI data at each image 
point, these results are consistent with the theory that diffusion measurements reported by 
MR correlate spatially with protein signatures obtained via MALDI methods.  
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Figure 10: Correlations between ADC and eigenimages for each slice of control and 
tumor rat data.  Correlations were classified as statistically significant when their 
associated p-values were ≤  0.05.  Significant correlations were found between the two 
metrics in a total of 44.0% of calculations for both rats 
 
Correlations between ADC and Selected Eigenimages 
 The results described above show that ADC and eigenimage intensities within 
selected anatomical regions of healthy and tumorous rat brains correlated in 44.0% of 
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comparisons between 114 ROIs and 20 eigenimages.  In order to examine the correlation 
between specific ADC populations and individual protein signatures, subsets of ROIs 
within the control and tumor rat data were selected for further analysis.  The ROIs 
included in these subgroups exhibited two features: (1) ADC values in the ROI were 
statistically similar at each depth (slice) in the rat head and (2) ADC values in the ROI 
were statistically different from those of other ROIs in the same slice which were chosen 
for further examination. 
 In the control rat, three ROIs were selected for further correlation analysis.  The 
first ROI which was found to exhibit statistically similar ADC values in all three slices of 
control rat data (criterion (1) for continued analysis) was located in the rhinal incisura.  
The right superior colliculus was also characterized by statistically similar ADC values in 
all three slices of control rat data.  In addition, the ADC values in the rhinal incisura and 
right superior colliculus differed statistically from one another within each slice (criterion 
(2) for continued analysis).  The ADC populations in the right lateral cerebellum were 
similar in slices two and three, yet statistically different from the ADCs of this ROI in 
slice one, meeting criterion (1) for inclusion in 2/3 of the control rat dataset.  The ADC 
populations of the right lateral cerebellum also differed from those of the rhinal incisura 
and right superior colliculus, fulfilling criterion (2) for continuing analysis.  The 
relationships between ADCs in these three ROIs are summarized in Table 4.  The t-
statistic and p-values calculated during the two-sample t-tests used to generate Table 4 
are shown as Tables 10 and 11 in the Additional Tables portion of the Appendix. 
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Table 4: Summary of control rat ADC T-test results in selected ROIs.  Statistical 
difference (▬ = absent;  = present) of ADC populations is indicated for each slice and 
ROI comprising the control rat data subset used for continued analysis.  Within each 
slice, the ADCs of the rhinal incisura, right superior colliculus, and right lateral 
cerebellum are statistically dissimilar, while each ROIs' ADC values are statistically 
equivalent across slices.  The mean and standard deviation of the ADC values in each 
ROI are included for reference.  
 
 
ROI  
Rhinal 
Incisura Sup. Colliculus Cerebellum 
 
Slice 1 2 3 1 2 3 2 3 
1.5 ± 6x10-4 ▬ ▬ ▬      
1.1 ± 2x10-4    ▬ ▬ ▬   Mean ADC (x10-3 mm2/s) 
0.9 ± 2x10-4       ▬ ▬ 
 
  
 Having identified control rat ROIs in which the ADCs were unique on an intra-
slice basis but similar across slices, specific protein signatures which correlate with these 
diffusion trends are now sought.  As suggested by the incidence of 41.2% significant 
correlation calculations in the control rat, many ROIs correlated with one or more 
eigenimages.  For those ROIs in which statistically equivalent inter-slice diffusion rates 
correlated with more than one eigenimage, the eigenimage associated with the greatest 
mean inter-slice correlation was selected for continued spectral analysis.  For example, in 
each slice of control rat data, the right superior colliculus exhibited statistically similar 
ADC values and correlated with multiple eigenimages, including eigenimages 7, 15, and 
18.  The mean correlations between ADC and eigenimage intensity in the right superior 
colliculus for eigenimages 7, 15, and 18 were 0.324, 0.324, and 0.338, respectively.  
Thus, eigenimage 18 was chosen for further analysis due to its relatively higher mean 
correlation with ADC in the right superior colliculus, while eigenimages 7 and 15 were 
excluded from further analysis associated with this ROI.  Eigenimage 18 and the location 
of the right superior colliculus within it are shown in Figure 11.  The subset of 
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eigenimages with which control rat ROIs in the rhinal incisura, right superior colliculus, 
and right lateral cerebellum correlated is described in Table 5.   
 
 
Figure 11: Eigenimage 18 for control rat slice one.  The ADCs and eigenimage intensities 
correlated significantly (rmean = 0.338) in the right lateral superior colliculus, which is 
identified in the figure as the ROI outlined in black. 
 
Table 5: Control rat selected ROI correlations with three different eigenimages.  For each 
slice and ROI, the eigenimage number, the Pearson correlation coefficient (r), and the 
associated p-values are given. 
 
ROI Rhinal Incisura Superior Colliculus Cerebellum 
Slice 1 2 3 1 2 3 2 3 
Eigenimage 4 4 4 18 18 18 3 3 
r-value 0.532 0.414 0.548 0.333 0.288 0.395 0.487 0.206 
p-value 0.000 0.026 0.010 0.016 0.026 0.004 0.000 0.007 
  
 Similarly to the control rat, three ROIs for the tumor rat were selected for further 
correlation analysis.  The ROIs were located in the medio-lateral cortex, the general 
region of the right hippocampus, and the inner core of the tumor.  However, ROIs which 
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exhibited statistically equivalent inter-slice ADC populations were observed in only the 
first and third slices.  Thus, in order to maintain consistent methodology in processing the 
data from both rats, it was necessary to omit the second (middle) tumor rat slice from 
continued examination.  All intra-slice ADC values for each ROI in the continuing 
analysis subset differed statistically from those of the other ROIs.  The ADC t-test results 
are summarized in Table 6, with the corresponding t-statistic and p-values given as 
Tables 12 and 13 in the Additional Tables portion of the Appendix. 
 
Table 6: Summary of tumor rat ADC T-test results.  Statistical difference (▬ = absent;  
= present) of ADC populations is indicated for each slice and ROI comprising the tumor 
rat data subset used for continued analysis.  Within each slice, the ADCs of the 
mediolateral cortex, hippocampus, and tumor core are statistically dissimilar, while each 
ROIs' ADC is statistically equivalent across slices.  The mean and standard deviation of 
the ADC values in each ROI are included for reference.  
 
 ROI  
Mediolateral 
Cortex  Hippocampus Tumor Core 
 Slice 1 3 1 3 1 3 
0.9 ± 2x10-4 ▬ ▬     
1.4 ± 2x10-4   ▬ ▬   
Mean ADC 
(x10-3 mm2/s) 
1.1 ± 3x10-4     ▬ ▬ 
 
 As was found with the control rat, ROIs in the tumor rat often exhibited 
correlations with multiple eigenimages.  Again as with the control rat, overlap was 
identified in the subset of eigenimages with which the selected ROIs correlated, as shown 
in Table 7.  An example eigenimage of correlation is given in Figure 12, which was 
found to have a mean correlation of 0.330 with the ADC values in the voxels located 
within the central core of the tumor.  
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Table 7: Tumor rat selected ROI correlations with three different eigenimages.  For each 
slice and ROI, the eigenimage number, the Pearson correlation coefficient (r), and the 
associated p-values are given. 
 
ROI Mediolateral Cortex Hippocampus Tumor Core 
Slice 1 3 1 3 1 3 
Eigenimage # 18 18 1 1 2 2 
r-value 0.308 0.567 0.221 0.207 0.392 0.268 
p-value 0.001 0.000 0.002 0.005 0.001 0.017 
 
 
 
Figure 12: Eigenimage 2 for tumor rat slice three.  The ADCs and eigenimage intensities 
correlated significantly (rmean = 0.330) in the central core of the tumor, which is identified 
in the figure as the ROI outlined in black. 
 
Selected Eigenspectra of Significant ADC Correlation 
 While each eigenimage represents the relative concentration of MALDI data in 
space, the corresponding eigenspectrum denotes which specific mass to charge ratios 
generate the peak amplitude intensities which give rise to variations in the eigenimage.  
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Thus, the eigenspectra of eigenimages which correlate with ADC populations in the 
above results are now inspected for protein identification.   
 Figure 13 plots the eigenspectra peak amplitude versus the mass to charge ratio 
for eigenspectrum 4, which correlates with ADC populations in the rhinal incisura, in 
each of the control rat slices.  Although MALDI data was collected on the range of 2 – 40 
kDa/charge, the sensitivity in the control rat data falls off rapidly beyond the 14 
kDa/charge range (top panel).  Examination of these independent eigenspectra on 
restricted ranges (bottom panels) yields the qualitative observation that the peaks are 
well-aligned, particularly in the 2 – 5 kDa/charge range (left bottom panel).  Thus, not 
only do the same proteins (points in each plot) appear to be present in the tissue of the 
control rat in the rhinal incisura, but their concentrations vary quite similarly (peak rise 
and fall).  The alignment of the peak location and amplitude decreases somewhat as the 
mass to charge ratio increases, which may reflect either or both of the following: 
variations in the presence and concentration of high molecular mass proteins and 
decreasing sensitivity.  Plots of eigenspectra which correlate with control rat ROIs in the 
right superior colliculus and the right lateral cerebellum can be found as Figures 21 and 
22 in the Additional Figures portion of the Appendix. 
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Figure13: Control rat eigenspectrum 4 for all three slices.  The corresponding eigenimage 
correlated significantly with the rhinal incisura in the control rat data.  The peaks in each 
slice's eigenspectrum appear qualitatively similar, especially for low mass to charge 
ratios, indicating the similarity of proteins as well as their concentrations in the rhinal 
incisura in each slice of the control rat data.  The peaks spread apart both in amplitude 
and location as mass to charge ratio increases, implying somewhat greater variations in 
the presence of high-mass proteins in the rhinal incisura.  Sensitivity falls off sharply 
beyond 14 kDa/charge. 
 
 Figure 14 plots the eigenspectra peak amplitude versus the mass to charge ratio 
for eigenspectrum 2 for tumor rat slices one and three.  This eigenspectrum was found to 
correlate well with the ADCs of central tumor core in the two tumor rat slices.  The 
sensitivity of MALDI data for the tumor rat data is much lower than that for the control 
rat beyond approximately 6 kDa/charge, with the signal disappearing entirely for tumor 
rat slice one at around 11 kDa/charge.  Qualitatively, the peaks in this eigenspectrum are 
somewhat less well-aligned than those in the control rat eigenspectra.  In the 2 – 4 
kDa/charge range (left bottom panel), the location of the peaks are relatively well-
matched between the eigenspectrum of the first and third slice.  Furthermore, the peaks'  
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Figure 14: Tumor rat eigenspectrum 2 for slices one and three.  The corresponding 
eigenimage correlated significantly with the central core of the tumor in the tumor rat 
data.  Throughout the range of mass to charge ratios, the peaks in each slice's 
eigenspectrum frequently appear with moderately qualitatively similar amplitudes and 
locations, suggesting that multiple proteins of similar mass and concentration are present 
in both slices of the tumor data.  Sensitivity of the tumor rat MALDI data falls off sharply 
beyond 11 kDa/charge. 
 
amplitudes are at similar heights, indicating that the same low-mass proteins may be 
present in both slices, with relatively similar concentrations.  The locations and 
amplitudes of the peaks differ increasingly as the mass to charge ratio increases, 
suggesting that the protein content of the two data slices varies increasingly for higher-
mass proteins.  Plots of eigenspectra which correlate with tumor rat ROIs in the region of 
the right hippocampus and the mediolateral cortex can be found as Figures 23 and 24 in 
the Additional Figures portion of the Appendix.  The results of this portion of the study 
are consistent with the theory that similar ADC populations within specific tissue types 
correlate with eigenspectra characterized by qualitatively similar protein profiles and 
concentrations. 
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Identification of Protein Signatures in MALDI Spectra 
 To identify specific proteins which may be represented by the mass to charge 
ratios of the eigenspectra which correlate with ADC values in selected ROIs, it is first 
assumed that the most likely charge of the ionized protein is +1.  Justification of this 
assumption is based upon consideration that an acidic matrix was used for analyte 
ionization and that the probability of MALDI formation of multiply charged ions 
decreases with molecular mass, becoming unlikely for low-mass (< 100 kDa) proteins 
such as those observed in this study [59]. 
 The range of proteins selected for identification was limited on the low end (2 – 6 
kDa) by the preponderance of low-mass peptides and fragmented protein subunits in this 
mass range.  Within the higher range of molecular masses (> 13 kDa), identification of 
proteins was not attempted because of the low sensitivity of the MALDI data in this mass 
range.  However, between the molecular mass range of 7.5 – 12.5 kDa, peaks were 
identified in eigenspectra of interest which correspond in the literature to six known 
proteins, with agreement at the mass resolution of 100 Da.  The first such set of peaks is 
shown in Figure 15 in eigenspectra 4 of three data slices in the control rat at 7.5 kDa, 
representative of insulin-like growth factor II (IGF II) [60, 61].  The IGF II peak is 
isolated in the dark gray rectangle near other observed peaks at 7.6 kDa (to two 
significant digits). 
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Figure 15: Eigenspectrum 4 from the 7.4 – 7.6 kDa range for all three slices in the control 
rat data.  Peaks are observed in all three spectra about the 7.5 kDa/charge point (dark gray 
rectangle).  Assuming a charge of +1, the mass to charge ratio represents the presence of 
IGF II.  Also visible are peaks at ~ 7.6 kDa, which were not found in the literature.  
 
 Multiple peaks were present in the range of eigenspectra amplitudes targeted for 
investigation.  However, a limited number of unambiguous peaks were chosen for ease of 
identification.  In all, five other proteins including insulin-like growth factor I, ubiquitin, 
acyl-CoA binding protein (structurally identical to diazepam-binding inhibitor [62]), 
parvalbumin, and cytochrome c were identified in the same manner of visual inspection 
of peaks in eigenspectra of correlation with ADC.  These proteins are described in Table 
8. 
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Table 8: Description of six proteins identified in the control and tumor rat.  These 
proteins were each found in eigenspectra of correlation with ADC in selected ROIs in the 
control and tumor rat. 
 
Name Abbr. Mass (kDa) Description Source 
Insulin-Like Growth 
Factor II IGF II 7.5 supports neuronal growth and survival  60; 61 
Insulin-Like Growth 
Factor I IGF I 7.7 
supports neuron, improves wound 
healing  63 
Ubiquitin ▬ 8.5, 8.6 target proteins for degradation 64; 65 
Acyl-CoA Binding 
Protein/ Diazepam-
Binding Inhibitor 
ACBP/DPI 9.9 binds fatty acids to proteins  
62, 66 
Parvalbumin PARV 12.1 
calcium binding protein, global second 
messenger 67 
Cytochrome C ▬ 
12.4, 
12.5 
involved in electron transport chain and 
apoptosis  68-70 
 
 Two of the proteins identified in the spectral data were each described in literature 
at more than one molecular mass.  Specifically, ubiquitin is described as both an 8.5 and 
8.6 kDa protein [65 and 64, respectively] while cytochrome c is found as both a 12.4 and 
12.5 kDa protein [69 and 70, respectively].  For the former protein, peaks in eigenspectra 
of interest were identified at both masses in all sets of control and tumor rat data.  For the 
latter, peaks were found in all three slices of the control rat data, whereas the low 
sensitivity of MALDI data for the tumor rat prohibited definitive assessment of the 
presence or lack of the protein.  Similarly, the presence of parvalbumin could not be 
determined in the tumor rat data, while the protein was found in all slices of the control 
rat data.  In contrast, IGF II was found in all slices of the control rat data and in slice 
three of the tumor rat data, but was absent in slice one of the tumor rat data.  These 
findings are summarized in Table 9. 
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Table 9: Location of six proteins identified in the control and tumor rat.  These proteins 
were identified in eigenspectra of significant correlation with ADC in selected ROIs of 
control and tumor rat data.  The mass to charge ratio is assumed equal to the mass.  The 
eigenspectra in which the proteins were identified can be located in the left column of the 
table.  IGF II was identified in all slices of the control rat data and in slice 3 of the tumor 
rat data. IGF I, ubiquitin, and ACBP/DBI were found in all data.  Parvalbumin and 
cytochrome c were present in the control rat data but assessment of their presence in the 
tumor rat dat was precluded by low MALDI sensitivity in the >12 kDa mass range.  
(Abbreviations: ES = Eigenspectrum; C = Control rat; T = Tumor rat; Y = yes for all 
slices; S3 = slice 3). 
  
 Mass (kDa) 7.5 7.7 8.5 and 8.6 9.9 12.1 12.4 and 12.5 
 
Protein IGF II IGF 1 Ubiquitin ACBP/ DBI PARV Cytochrome C 
C - ES 4  
rhinal incisura Y Y Y Y Y Y 
C - ES 18  
superior 
colliculus Y Y Y Y Y Y 
C - ES 3 
cerebellum Y Y Y Y Y Y 
T - ES 18  
cortex S3 Y Y Y N/A N/A 
T - ES 1  
hippocampus S3 Y Y Y N/A N/A 
D
a
ta
 L
o
ca
tio
n
 
T - ES 2  
tumor core S3 Y Y Y N/A N/A 
 
 While this portion of the analysis has identified several proteins which may give 
rise to correlations between ADC values and low molecular mass protein signatures in 
both healthy and tumorous rat brain tissues, these results are unable to address the 
correlations that may exist between ADC populations and higher molecular mass 
proteins, due to the insensitivity of the collected MALDI data beyond the mass range of 
approximately 12.5 kDa/charge.  However, the results described herein demonstrate a 
novel technique for identification of correlations between non-invasive MR 
measurements and their underlying molecular-level contrast sources.  
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CHAPTER II 
 
CONCLUSIONS  
 
 While the results of this study have yielded initial support for the theory that 
molecular-level proteomic expression correlates with contrast in diffusion-weighted MR 
data, they have also exposed some of the underlying difficulties inherent to analysis of 
hybrid data.  Technical complications arose during data acquisition, including loss of 
coregistered MR and MALDI tumor rat data due to misalignment of the head during 
sectioning.  This factor confounded accurate delineation of ROIs corresponding to 
specific anatomical structures in the tumor rat, thus complicating quantification 
techniques.  Moreover, ADC artifacts observed in the tumor rat MR data further draw 
into question the source of results in correlation calculations, since the heterogeneous 
"streaks" in the data make it difficult to localize ADC variations. 
 While MALDI techniques have been gaining both favor and technological 
advancements in recent decades, several obstacles have yet to be overcome in the 
methods.  For example, identification of specific proteins in spectral data is hindered by 
proteomic processes including phosphorylation, dimerization, and fragmentation.  
Furthermore, the lack of ability to discriminate the exact charge transferred by the matrix 
to the analyte constitutes an additional problem.  While the latter factor most probably 
did not impact the results of this study, owing to the low molecular masses involved (and 
their consequent unlikelihood of being multiply charged during ionization), acquisition of 
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MALDI data over a wider range of mass to charge ratios suffers to a greater extent from 
this limitation. 
 This study used fewer subjects than many cohort studies, suggesting an inability 
to assess repeatability.  However, it should be noted that each mass spectrum in each 
pixel in each data slice constituted an independent measurement, thus generating a large 
volume (~ 106 measurements) of data.  Hence, the observation of repeated eigenspectra 
peaks and amplitudes at specific mass to charge ratios in different data sets offers some 
insight into the repeatability of results described herein.    
 The objective of this thesis was to elucidate the molecular-level influences on 
ADC variations in a C6 rat glioma model of brain cancer.  The results obtained during the 
course of this project suggest that proteomic profiles exert a substantial influence on 
diffusion metrics.  However, this study constitutes only an early step towards the 
overarching goal of improving clinical cancer care by using non-invasive methods to 
monitor cellular-level tumor status.  Future studies to verify and expand upon these 
preliminary findings are necessary to determine the feasibility of these techniques for 
large-scale studies. 
 Future work should incorporate several variations from the methodology of this 
study.  First, additional care should be taken during the sectioning procedures in order to 
achieve higher-quality specimen slices for MALDI data acquisition.  Several MR 
imaging parameters may be modified to increase resolution and signal-to-noise ratio, 
including decreasing the slice width and increasing the number of image acquisitions 
averaged for each rat.  Similarly, decreasing the operating frequency of the MALDI laser 
and the matrix spot diameter and gap would increase data quality.  Furthermore, the range 
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of mass to charge ratios at which proteomic metrics are collected should be expanded to 
70 kDa/charge, as many proteins generally upregulated in cancer and specifically 
overexpressed in the C6 line have molecular masses well above 40 kDa (e.g., activated 
matrix metalloproteinase-2 ~ 62 kDa [71]; poly(ADP-ribose) glycohydrolase ~ 53 - 85 
kD [72]; and vascular endothelial growth factor ~ 45 kDa [73, 74]). 
 Future research would also benefit by a change in several study parameters.  
Consider a study using the techniques described in this thesis and the imaging parameters 
described above in which six rats were used as follows: two control, two in which a C6 
model of brain cancer was implemented, and two in which the RG2 model of brain 
cancer was implemented.  While the data acquisition time and the volume of data 
generated would both be increased substantially, the study would offer the opportunity to 
investigate several important questions.  First, the project would provide validation of or 
refute the correlations found in this work between ADC and protein signatures.  
Secondly, the increase in data resolution and the use of two different cell lines would 
provide the information necessary to examine whether there might exist not only a 
correlation between ADC and protein expression, but a correlation between patterns in 
ADC and protein expression.  Identification of trends in the two metrics or their 
differentials would begin to address the feasibility of the clinical use of diffusion-
weighted MR as a proxy for latent molecular-level proteomic information. 
 In summary, this study examined ADC and MALDI data which were acquired for 
a control rat and a rat in which C6 glioma cells were implanted.  Principal component 
analysis was applied to the MALDI data to yield a set of 20 independent eigenimages, 
each voxel of which represented the relative concentration of MALDI data at a specific 
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spatial location.  The ADC values and eigenimage intensities were compared within 114 
selected anatomical regions using the linear Pearson correlation coefficient.  The two data 
sets correlated significantly (p-value ≤  0.05) in 44.0% of the comparisons.  Six ROIs 
(three in the control rat data and three in the tumor rat data) were identified which 
exhibited statistically dissimilar ADC values when compared with those of the other 
ROIs on an intra-slice basis while concurrently exhibiting statistically equivalent values 
at each depth within the rat head.  Eigenimages which correlated with the ADC 
populations in these ROIs were used to identify eigenspectra to be examined for the 
presence of specific protein signatures.  It was found that similar ADC populations within 
specific tissue types correlate with eigenspectra characterized by qualitatively similar 
protein profiles and concentrations.  Six low-mass proteins (IGF I and II, ubiquitin, 
ACBP/DPI, parvalbumin, and cytochrome c) were identified in the eigenspectra which 
correlated with ADC measurements in selected anatomical regions within the control and 
tumor rat.  Signatures of proteins having masses greater than approximately 13 kDa could 
not be identified in the eigenspectra, due to low sensitivity to higher-mass proteins during 
the MALDI data acquisition process.  The methods developed in this study constitute a 
novel approach for identification of correlations between non-invasive MR measurements 
and their underlying molecular-level contrast sources.  
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APPENDIX 
 
A. ADDITIONAL FIGURES 
 
 
 
 
Figure 16:  ROIs in ADC data translated into MALDI space for control rat slice one.  The 
ROIs are numbered such that anatomical structures across slices are identified by 
identical ROI numbers. 
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Figure 17:  ROIs in ADC data translated into MALDI space for control rat slice two.  The 
ROIs are numbered such that anatomical structures across slices are identified by 
identical ROI numbers. 
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Figure 18:  ROIs in ADC data translated into MALDI space for control rat slice three.  
The ROIs are numbered such that anatomical structures across slices are identified by 
identical ROI numbers.  The absence of ROIs 8, 10, 11, and 22-24 in this data slice are 
due maintenance of a numbering scheme which identifies similar structures across slices 
by identical numbers.  The omitted ROI numbers correspond to absence of structures at 
the depth of the third slice which were present in the first two slices.  
 51 
 
Figure 19: ROIs in ADC data translated into MALDI space for tumor rat slice two.  Data 
quality reflects misalignment of the rat head during the two different data acquisition 
processes and heterogeneous MR data distributed across the resolution of the MR 
scanner.  The diffusion rates in the ROIs of this slice were not statistically equivalent to 
those in the ROIs of slices one and three, necessitating the omission of this data slice 
from inter-slice spectral analysis. 
 52 
 
Figure 20: ROIs in ADC data translated into MALDI space for tumor slice three.  Data 
quality reflects misalignment of the rat head during the two different data acquisition 
processes and heterogeneous MR data distributed across the resolution of the MR 
scanner. 
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Figure 21: Control rat eigenspectrum 18 for all three slices.  The corresponding 
eigenimage correlated with the right superior colliculus in all three slices of the control 
rat data (Table 3).  Many peaks in this eigenspectrum share similar amplitudes, locations 
along the mass to charge ratio axis, or both.  This suggests the presence of multiple 
proteins which are similar across two or more slices.  However, the peaks are not as well-
aligned as those in eigenspectrum 4, which correlated with the rhinal incisura, indicating 
a lower degree of inter-slice protein signature similarity in right superior colliculus 
relative to the rhinal incisura.  Sensitivity falls off sharply beyond 14 kDa/charge. 
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Figure 22: Control rat eigenspectrum 3 for slices 2 and 3.  Eigenimage 3 correlated well 
with the right lateral cerebellum in the second and third slice of the control rat data (Table 
3). Relative to the eigenspectra for ROIs in the rhinal incisura and right superior 
colliculus of the control rat, the peaks in this eigenspectrum are moderately similar in 
amplitude, location along the mass to charge ratio axis, or both.  This suggests the 
presence and concentration of multiple proteins which are similar across two or more 
slices in cerebellum.  The degree of inter-slice protein signature similarity in the 
cerebellum appears greater than that of the right superior colliculus , yet less than that of 
the rhinal incisura.  Sensitivity falls off sharply beyond 14 kDa/charge. 
 55 
 
 
Figure 23: Tumor rat eigenspectrum 1 for slices one and three.  The corresponding 
eigenimage correlated significantly with the right hippocampus in the tumor rat data.  
Throughout the range of mass to charge ratios, the peaks in each slice's eigenspectrum 
frequently appear with qualitatively dissimilar amplitudes.  However, many points on the 
plots of both spectra appear at similar mass to charge ratios, suggesting that, while 
multiple proteins of similar mass are present in both slices of the tumor data, their 
concentrations in the right hippocampus of the tumor rat vary according to slice position.  
Sensitivity of the tumor rat MALDI data falls off sharply beyond 11 kDa/charge. 
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Figure 24: Tumor rat eigenspectrum 18 for slices one and three.  The corresponding 
eigenimage correlated significantly with the mediolateral cortex in the tumor rat data.  
Throughout the range of mass to charge ratios, the peaks in each slice's eigenspectrum 
frequently appear with qualitatively dissimilar amplitudes.  However, many points on the 
plots of both spectra appear at similar mass to charge ratios, suggesting that, while 
multiple proteins of similar mass are present in both slices of the tumor data, their 
concentrations in the mediolateral cortex of the tumor rat vary according to slice position.  
Sensitivity of the tumor rat MALDI data falls off sharply beyond11 kDa/charge. 
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B. ADDITIONAL TABLES 
 
 
Table 8: T-Statistics for ADC t-test in control rat ROIs 
  
Rhinal Incisura 
Superior 
Colliculus Cerebellum 
 
Slice 1 2 3 1 2 3 2 3 
1 0 0.69 0.42 4.2 4.92 4.76 8.18 10.71 
2 0.69 0 0.3 3.69 4.24 4.08 6.61 8.91 Rhinal Incisura 
3 0.42 0.3 0 6.67 7.45 6.78 11.27 12.96 
1 4.2 3.69 6.67 0 1.22 1.72 -7.07 7.61 
2 4.92 4.24 7.45 1.22 0 0.72 5.87 6.49 Superior Colliculus 
3 4.76 4.08 6.78 1.72 0.72 0 4.23 4.85 
2 8.18 6.61 11.27 7.07 5.87 4.23 0 0.13 Cerebellum 
3 10.71 8.91 12.96 7.61 6.49 4.85 0.13 0 
 
 
Table 9: P-Values for ADC t-test in control rat ROIs 
  
Rhinal Incisura Superior Colliculus Cerebellum 
 
Slice 1 2 3 1 2 3 2 3 
1 1 0.494 0.676 0.000 0.000 0.000 0.000 0.000 
2 0.494 1 0.764 0.000 0.000 0.000 0.000 0.000 Rhinal Incisura 
3 0.676 0.764 1 0.000 0.000 0.000 0.000 0.000 
1 0.000 0.000 0.000 1 0.224 0.088 0.000 0.000 
2 0.000 0.000 0.000 0.224 1 0.471 0.000 0.000 Superior Colliculus 
3 0.000 0.000 0.000 0.088 0.471 1 0.000 0.000 
2 0.000 0.000 0.000 0.000 0.000 0.000 1 0.897 Cerebellum 
3 0.000 0.000 0.000 0.000 0.000 0.000 0.897 1 
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Table 10: T-Statistics for ADC t-test in tumor rat ROIs 
  Cortex  Hippocampus Tumor Core 
 Slice 1 3 1 3 1 3 
1  0 0.45 19.31 22 3.39 5.53 
Cortex  3 0.45  0 19.77 22.5 3.66 5.94 
1 19.31 19.77 0  1.37 9.16 12.4 
Hippocampus 3 22 22.5 1.37 0  9.36 14.38 
1 3.39 3.66 9.16 9.36 0  0.05 
Tumor Core 3 5.53 5.94 12.4 14.38 0.05 0  
 
 
 
Table 11: P-Values for ADC t-test in tumor rat ROIs 
  Cortex  Hippocampus Tumor Core 
 Slice 1 3 1 3 1 3 
1 
 1 0.652 0.000 0.000 0.001 0.000 
Cortex  3 0.652 1  0.000 0.000 0.000 0.000 
1 0.000 0.000  1 0.172 0.000 0.000 
Hippocampus 3 0.000 0.000 0.172  1 0.000 0.000 
1 0.001 0.000 0.000 0.000  1 0.964 
Tumor Core 3 0.000 0.000 0.000 0.000 0.964 1  
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